Scientists create biological ‘artificial intelligence’ system
On Jul. 7, 2025, Australian scientists, including at the Charles Perkins Centre, University of Sydney, have successfully developed…
On Jul. 7, 2025, Australian scientists, including at the Charles Perkins Centre, University of Sydney, have successfully developed…
On Jan. 29, 2025, researchers at The University of Queensland announced they have identified the first henipavirus in…
On Jan. 9, 2025, clinicians from the The University of Queensland (UQ) announced they had successfully used custom-made…
On Jan. 7, 2025, scientists at The University of Queensland (UQ) and the University of Sydney announced they…
On Dec. 19, 2024, a University of Queensland (UQ) study has found no link between exposure to water…
On Dec. 18, 2024, BiVACOR, a clinical-stage medical device company, announced the successful completion of the first phase…
On Dec. 17, 2024, scientists at The University of Queensland (UQ) announced they had licensed a promising ultrasound…
On Dec. 5, 2024, researchers Dr Sonia Shah and Dr Clara Jiang from the University of Queensland’s Institute…
On Nov. 11, 2024, an international team of researchers has for the first time cured patients with Toxic…
On Oct. 17, 2024, Colossal Biosciences, an American biotechnology and genetic engineering company, announced that it has a…
On Oct. 8, 2024, scientists from the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency,…
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
On Feb. 16, 2024, the Australian Government announced it had issued QUT a licence to commercially release QCAV-4,…
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
On Jun. 13 2022, Novavax announced that the Australian Therapeutic Goods Administration (TGA) had granted provisional registration of…
On Feb. 23, 2022, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…
On Jan. 19, 2022, Novavaxa announced that Australia’s Therapeutic Goods Administration had granted approval for provisional registration of…
On Dec. 13, 2021, Moderna announced an agreement with the Australian Government to build a state-of-the-art messenger RNA…
On Oct. 29, 2021, Novavax announced the completion of its rolling submission to the Therapeutic Goods Administration (TGA)…
On Jan. 7, 2021, Novavax announced that it had executed an Advance Purchase Agreement with the Commonwealth of…
On Nov. 4, 2020, Novavax announced the signing of a non-binding Heads of Terms document with the Australian…
On Oct. 6, 2020, the U.S. Department of Health and Human Services (HHS) announced funding of a patch…
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
In 2006, the Malaria Atlas Project (MAP) was founded as an international research collaboration that tracks the global…
In 1996, the first official case of devil tumor facial disease was reported. Devil Facial Tumour Disease (DFTD)…